StudyRareStudyRare

Kallmann syndrome

Log in to star

Last updated Nov 4, 2026

Log in to add personal notes on this page.

A 17-year-old male has not entered puberty. He has anosmia (cannot smell). MRI shows hypoplastic olfactory bulbs.

Heterogeneous; XLR (ANOS1, formerly KAL1, encoding anosmin 1), AD (FGFR1, FGF8), AR, and oligogenic. Kallmann syndrome is typically caused by neurodevelopmental genes that govern the origin of GnRH neurons.

Kallmann syndrome is the form of isolated GnRH deficiency with a poor sense of smell. GnRH neurons migrate from the olfactory placode alongside olfactory neurons. Neurodevelopmental genes that govern this origin typically cause Kallmann syndrome, while genes for GnRH secretion or action (GNRHR, KISS1R, TACR3) cause the normosmic form. The shared route is why one defect removes both smell and puberty.

  • ANOS1: anosmin 1 carries fibronectin type III repeats like those of neural cell adhesion molecules. Deletions and missense, nonsense, and splice variants impair migration of olfactory and GnRH neurons and malform the olfactory bulbs seen on MRI. Digital synkinesia (about 80%) and unilateral renal agenesis (about 30%) occur in affected males.
  • FGFR1: deletions and missense, nonsense, and splice variants impair receptor signaling. Cleft lip or palate, missing teeth, and digit malformations go with this gene. Anosmin gene dose and its interaction with this receptor have been proposed to explain the male predominance.
  • CHD7: mostly missense variants cause GnRH deficiency, while truncating variants give the fuller CHARGE syndrome.

In 10% to 15% of people with isolated GnRH deficiency, variants in two or more genes act together (oligogenic inheritance), which may explain some of the variable expressivity and reduced penetrance.

  • Hypogonadotropic hypogonadism (low FSH/LH)
  • Anosmia or hyposmia (defective olfactory neuron migration)
  • Absent/delayed puberty
  • May have renal agenesis, cleft palate, hearing loss
  • Low sex steroids (testosterone/estradiol) with inappropriately low or normal LH/FSH (hypogonadotropic hypogonadism)
  • Confirmed anosmia/hyposmia distinguishes Kallmann from normosmic isolated hypogonadotropic hypogonadism; MRI shows hypoplastic or absent olfactory bulbs
  • Multigene panel testing (ANOS1/KAL1, FGFR1, FGF8, PROK2, PROKR2, CHD7, others); inheritance and associated features guide interpretation
  • Screen for associated anomalies: renal ultrasound (unilateral renal agenesis), audiometry, dental/palate exam
  • Pubertal induction and maintenance with sex steroid replacement (testosterone in males; estrogen then estrogen-progestin in females)
  • Fertility induction with gonadotropins (hCG plus FSH) or pulsatile GnRH when conception is desired
  • Bone density monitoring; long-term hormone replacement preserves bone health
  • Genetic counseling reflecting locus heterogeneity (X-linked, autosomal dominant, autosomal recessive forms)

Anosmia → ANOS1: the gene is named for the sign. ANOS1 (formerly KAL1) encodes anosmin-1, which guides olfactory and GnRH neurons from the nose into the forebrain. It is X-linked recessive, so it affects males. It was the first Kallmann gene found (1991) and accounts for about 8% of cases, close to FGFR1 (about 10%, autosomal dominant).

Reference Links